• ქართული
  • English
  • Mylan shares slide after warning of hit to revenue

    Generic drugmaker Mylan NV said on Tuesday reevaluation of its portfolio of medicines will continue next year and cautioned of a hit to revenue, and its shares nearly 6%.

    Market Quotes by TradingView